Emerging viral threats to the Australian blood supply

Australian and New Zealand Journal of Public Health

Volumn 32, Issue 4, 2008, Pages 354-360

  Dunstan, Robert A ^a   Seed, Clive R ^b   Keller, Anthony J ^c  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

Arboviruses; Blood transfusion; Emerging infectious diseases; Infection; Interventions; Transfusion transmission; Viruses

Indexed keywords

ARTICLE; AUSTRALIA; BARMAH FOREST VIRUS; BLOOD BANK; BLOOD TRANSFUSION; CLIMATE CHANGE; DENGUE VIRUS; DISEASE SURVEILLANCE; DONOR SELECTION; EPIDEMIC ENCEPHALITIS; HUMAN; INFECTION CONTROL; INFECTION RISK; KUNJIN VIRUS; LABORATORY TEST; MURRAY VALLEY ENCEPHALITIS VIRUS; NONHUMAN; NUCLEIC ACID ANALYSIS; POPULATION MIGRATION; RISK ASSESSMENT; RISK REDUCTION; ROSS RIVER ALPHA VIRUS; VIRAL CONTAMINATION; VIRUS INFECTION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ARBOVIRUS INFECTIONS; AUSTRALIA; BLOOD BANKS; BLOOD TRANSFUSION; HUMANS; RISK ASSESSMENT; RISK FACTORS; SAFETY; VIRUS DISEASES;

EID: 50449104973     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2008.00254.x     Document Type: Article

References (44)

1. Vijayanand P, Wilkins E, Woodhead M. Severe acute respiratory syndrome (SARS): a review. Clin Med. 2004 Mar-Apr;4(2):152-60.
2. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996 Apr 6;347(9006):921-5.
3. Dodd R. Other emerging viral pathogens. ISBT Science Series. 2006;1: 257-62.
4. Heneine W, Kuehnert MJ. Preserving blood safety against emerging retroviruses. Transfusion. 2006 Aug;46(8):1276-8.
5. Alter HJ. Emerging, re-emerging and submerging infectious threats to the blood supply (abstract). Vox sanguinis. 2004;87 (Supplement 2):56.
6. Lindsay M, Mackenzie IS. Vector-borne viral diseases and climate change in the Australasian region: Major concerns and the public health response. In: Curson P, ed. Climate change and human health in the Asia-Pacific region: Blackwell-Synergy 1998.
7. Lin CK. First documented case of transfusion transmitted dengue virus infection (abstract). 23rd NRL workshop on serology. Melbourne, Australia: http://nrl.gov.au/hosting/serology/nrl-pub.nsf/structure/ Events-NRLA-6P5V4J?OpenDocument 2006.
8. Nash D, Mostashari F, Fine A, Miller J, O'leary D, K. M, Huang A, Rosenberg A, Greenburg A, Shermman M, Wong S, Layton M & the 1999 West Nile outbreak response group. The outbreak of West Nile virus infection in the New York City area in 1999. New Engl J Med. 2001;344(24):1807-14.
9. Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, Prince HE, Bianco C, Foster G, Petersen LR, Nemo G, Glynn SA. West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis. 2006 Mar; 12(3):395-402.
10. Mackenzie IS, Smith DW, Hall RA. West Nile Virus: is there a message for Australia? Med J Aust. 2003;178:5-6.
11. Ligon BL. Dengue fever and dengue hemorrhagic fever: a review of the history, transmission, treatment, and prevention. Semin Pediatr Infect Dis. 2005 Jan; 16(1):60-5.
12. Russell RC, Dwyer DE. Arboviruses associated with human disease in Australia. Microbes and Infection. 2000;14:1693-704.
13. Charrel RN, de Lamballerie X, Raoult D. Chikungunya outbreaks - The Globalization of vectorborne diseases. New Engl J Med. 2007;356(8):769-71.
14. Druce JD, Johnson DF, Tran T, Richards MJ, Birch CJ. Chikungunya virus infection in a traveler to Australia (letter). Emerg Infect Dis. 2007;13(3):509-10.
15. Johnson DF, Druce JD, Chapman S, Swaminathan A, Wolf J, Richards JS, et al. Chikungunya virus infection in travellers to Australia. Med J Aust. 2008;188(1):41-3.
16. Dodd RY, Leiby DA. Emerging Infectious Threats to the Blood Supply Annu Rev Med. 2004;55:191-207.
17. Leroy EM, Baisze S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet. 2000;355(9222):2178-9.
18. Eaton BT, Mackenzie JS, Wang LF. Henipaviruses. In: Knipe DM, Howley, P.M., ed. Fields Virology. 5th ed. Philidelphia: Wolters Kluwer: Lippincott, Williams & Wilkins 2007:1587-600.
19. Guertler LG. Virus safety of human blood, plasma and derived products. Thrombosis Research 2002;107(Supplement 1):S39-S45
20. International Society for Infectious Diseases. Arenavirus, organ transplants-Australia (Victoria). ProMED-mail 2007; Archive number 2007 No. 195 (http://www.promedmail.org) accessed 24 April 2007
21. Palacios G, Druce JD, Tran T, Birch C, Briese T, Conlan S, Quan P, Hui J, Marshal J, Simons JF, Egholm M, Paddock CD, Shieh W, Goldsmith C, Zaki SR, Catton MD, Lipkin WI. A new arenavirus in a cluster of fatal transplant-associated diseases. New Engl J Med. 2008;358:1-8.
22. Likos AM, Kelvin DJ, Cameron CM, Rowe T, Kuehnert MJ, Norris PJ. Influenza viremia and the potential for blood-borne transmission. Transfusion. 2007;47:1080-8.
23. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis ofunknown etiology. Biochem Biophys Res Commun. 1997 Dec 8;241(1):92-7.
24. Tanaka Y, Primi D, Wang RY, Umemura T, Yeo AE, Mizokami M, Alter HJ, Shih JW. Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. J Infect Dis. 2001 Feb 1;183(3):359-67.
25. Alter HJ, Stramer SL, Dodd RY. Emerging infectious diseases that threaten the blood supply. Semin Hematol. 2007 Jan;44(1):32-41.
26. Australian Government Department of Health and Ageing. National Notifiable Diseases Network Surveillance System. Canberra: Commonwealth of Australia; 2007 [cited 2007 16 July 2007]; Available from: http://www.health.gov.au/cda-index.cfm
27. Communicable Diseases Network of Australia. Canberra: Commonwealth of Australia; 2007. Available from: www.health.gov.au/cda [cited 2007 16 July]
28. Japanese encephalitis on the Australian mainland. Aust Comm Dis Intell. 1998;22:80.
29. Australia's notifiable diseases status, 2005: Annual report of the National Notifiable Diseases Surveillance System Australian Comm Dis Intel. 2005;31(1).
30. Kitchen AD, Barbara JA. Which agents threaten blood safety in the future? Baillieres Best Pract Res Clin Haematol. 2000 Dec; 13(4):601-14.
31. Kleinman S. West Nile virus and transfusion safety in North America: response to an emerging pathogen. ISBT Science Series. 2006;1:251-6.
32. Seed CR, Kiely P, Keller AJ. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Intern Med J. 2005 Oct;35(10):592-8.
33. Bihl F, Castelli D, Marincola F, Dodd R, Brander C. Transfusion-transmitted infections. Journal of Translational Medicine. 2007;5(25):1-11.
34. Polizzotto MN, E.M. W, Ingham H, Keller AJ. Reducing the risk of transfusion-transmissible viral infection through blood donor selection:die Australian experience 2000 through 2006. Transfusion. 2008;48:55-63.
35. Mison L, Seed CR, Margaritis AR, Hyland C. Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies. Vox Sang. 2003 Jan;84(1):11-9.
36. Epstein JS. Insights on donor screening for West Nile virus. Transfusion. 2005 Apr;45(4):460-2.
37. Zou S. Potential impact of pandemic influenza on blood safety and availability. Transfus Med Rev. 2006 Jul;20(3):181-9.
38. Farrugia A. The regulatory pendulum in transfusion medicine. Transfus Med Rev. 2002 Oct; 16(4):273-82.
39. Margaritis AR, Brown SM, Seed CR, Kiely P, D'Agostino B, Keller AJ. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion. 2007;47:1783-93.
40. Lelie N, Heaton A. Hepatitis B - A review of the role of NAT in enhancing blood safety. J of Clin Virol. 2006;36 (supplement 1):S1-S2.
41. Petrik J, de Haas M, Denomme G, Scott M, Seghatchian J. Small world - Advance of microarrays: Current status and future trends. Transfus Aph Sci. 2007;36:201-6.
42. Burnouf T, Radosevich M. Reducing the risk of infection from plasma products: specific preventative strategies. Blood Rev. 2000;14:94-110.
43. Bryant BJ, Klein H. Pathogen Inactivation - The definitive safeguard for the blood supply. Arch Pathol Lab Med. 2007;131:719-33.
44. Klein H, Anderson D, M-J. B, Cable RG, Carey W, Hoch JS, Robitaille N, Sivilotti M, Smaill F. Pathogen inactivation: making decisions about new technologies - preliminary report of a consensus conference. Vox Sang. 2007;93:179-82.